These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7939073)

  • 21. [Neuropsychiatric disorders in Parkinson's disease].
    Noé-Sebastián E; Irimia-Sieira P; Pomares-Arias E; Martínez-Vila E; Luquin-Piudo MR
    Rev Neurol; 2001 Apr 1-15; 32(7):676-81. PubMed ID: 11391498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive and behavioural impairment in Parkinson's disease.
    Merims D; Freedman M
    Int Rev Psychiatry; 2008 Aug; 20(4):364-73. PubMed ID: 18925485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive dysfunction in early onset parkinsonism.
    Tsai CH; Lu CS; Hua MS; Lo WL; Lo SK
    Acta Neurol Scand; 1994 Jan; 89(1):9-14. PubMed ID: 8178636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's disease revisited.
    Herndon CM; Young K; Herndon AD; Dole EJ
    J Neurosci Nurs; 2000 Aug; 32(4):216-21. PubMed ID: 10994535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nighttime sleep problems and daytime sleepiness in Parkinson's disease.
    Verbaan D; van Rooden SM; Visser M; Marinus J; van Hilten JJ
    Mov Disord; 2008 Jan; 23(1):35-41. PubMed ID: 17960797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of sleep and Parkinson's disease.
    Razmy A; Shapiro CM
    Semin Clin Neuropsychiatry; 2000 Jan; 5(1):20-32. PubMed ID: 10704535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Other symptoms of advanced stage Parkinson's disease].
    Pollak P; Tranchant C
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():165-73. PubMed ID: 10916048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosis in Parkinson's disease: case studies.
    Salter BC; Anderson KE; Weiner WJ
    Neurol Clin; 2006 May; 24(2):363-9. PubMed ID: 16684637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Idiopathic Parkinson syndrome--current therapy].
    Ludin HP
    Ther Umsch; 1993 Nov; 50(11):771-4. PubMed ID: 8191382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autogenic training in geriatric psychiatry patients].
    Stetter F; Stuhlmann W
    Z Gerontol; 1987; 20(4):236-41. PubMed ID: 3660922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism.
    Frank MJ; Samanta J; Moustafa AA; Sherman SJ
    Science; 2007 Nov; 318(5854):1309-12. PubMed ID: 17962524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Optimal method of drug therapy of parkinsonism patients].
    Kurako IuL; Volianskiĭ VE; Ivanitskiĭ VL
    Vrach Delo; 1985 Jan; (1):99-102. PubMed ID: 3984341
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug therapy for Parkinson's disease.
    Hermanowicz N
    Semin Neurol; 2007 Apr; 27(2):97-105. PubMed ID: 17390254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rapid-eye-movement sleep disorders in Parkinson's disease].
    Gagnon JF; Montplaisir J; Bédard MA
    Rev Neurol (Paris); 2002 Feb; 158(2):135-52. PubMed ID: 11965170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Emotional and cognitive disorders in Parkinson disease].
    Arsland D; Larsen JP
    Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.
    Hely MA; Reid WG; Adena MA; Halliday GM; Morris JG
    Mov Disord; 2008 Apr; 23(6):837-44. PubMed ID: 18307261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Parkinson's disease a review of current and new therapies.
    Mendis T; Suchowersky O; Lang A; Gauthier S
    Can J Neurol Sci; 1999 May; 26(2):89-103. PubMed ID: 10352867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychiatric complications of L-dopa: physiopathology and treatment].
    Castro-García A
    Rev Neurol; 1997 Aug; 25 Suppl 2():S157-62. PubMed ID: 9280683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.